TRIGYN TECHNOLOGIES LTD.

Trigyn Technologies Ltd has announced the closure of its trading window for all designated persons and their immediate relatives. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will remain shut from July 1, 2026, until 48 hours after the declaration of the unaudited financial results for the quarter ended June 30, 2026. Insiders are advised not to trade in the company's equity shares during this period. The trading window will reopen 48 hours post-dissemination of the financial results to the stock exchanges.

Trigyn Technologies Ltd reported its financial results for the year ended March 31, 2026. On a consolidated basis, the company's revenue increased to ₹97,642.94 lakhs from ₹89,779.08 lakhs in the previous year. However, consolidated earnings after tax decreased to ₹198.66 lakhs from ₹1,176.94 lakhs. On a standalone basis, revenue increased to ₹18,895.46 lakhs from ₹15,307.91 lakhs, and earnings after tax increased to ₹566.63 lakhs from ₹136.86 lakhs.

Trigyn Technologies Ltd's board approved the audited standalone and consolidated financial statements for the year ended March 31, 2026. The audit report by V Rohatgi & Co. expressed an unmodified opinion. The board meeting, held on May 22, 2026, commenced at 05:30 P.M. and concluded at 10:20 P.M. The auditor's report highlights emphasis of matter related to the going concern status of two wholly-owned subsidiaries, RBI approvals under FEMA, and non-accounting of ₹80 Crores quarterly guaranteed revenue.

Trigyn Technologies Ltd has released its audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026. The results were approved at a Board of Directors meeting held on May 22, 2026. V Rohatgi & Co, Statutory Auditors, issued an audit report with an unmodified opinion on the financial results and statements. The board meeting commenced at 05:30 P.M. and concluded at 10.20 P.M.

Trigyn Technologies Ltd has scheduled a Board of Directors meeting on May 22, 2026, to consider and approve the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The trading window for dealing in the company's securities has been closed for designated persons from April 1, 2026, and will remain closed until 48 hours after the declaration of the audited financial results.

Trigyn Technologies responded to a BSE query regarding significant movement in its equity share price. The company affirmed its full compliance with SEBI (LODR) Regulations, 2015, including Regulation 30, and stated it has consistently and promptly disclosed all material information. Trigyn confirmed there is no undisclosed material information or impending announcement that could influence the share price. The company attributes the price movement to market forces, over which it has no control, and reiterated its commitment to transparency and timely disclosures to the Stock Exchange(s).

Trigyn Technologies Ltd has announced that the trading window for dealing in securities of the company will remain closed from April 01, 2026, till 48 hours after the declaration of audited standalone and consolidated financial results for the quarter and financial year ended on March 31, 2026. This closure is as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Insider Trading Regulation Code. All Connected Persons / Designated Persons are advised not to trade in securities of the Company during this period.

Trigyn Technologies Ltd has announced the resignation of Dr Satyam Cherukuri from the positions of Chairman and Non-Executive Director, effective from April 7, 2026. The resignation is due to personal circumstances requiring his full attention and commitment. Dr Cherukuri has also stepped down as a Member of the Board of Trigyn Technologies Inc., a subsidiary of the Company. The Company has expressed its sincere appreciation for the valuable contributions made by Dr Cherukuri during his tenure.

Trigyn Technologies Ltd has announced the resignation of Dr Satyam Cherukuri as Chairman and Non-Executive Director of the Company and as a Member of the Board of Trigyn Technologies Inc., a subsidiary of the Company. The resignation is due to personal circumstances requiring his full attention and commitment. The resignation will be effective from April 7, 2026. The Company has expressed its sincere appreciation for the valuable contributions made by Dr Satyam Cherukuri during his tenure.

Trigyn Technologies Ltd has announced the financial results for the quarter and nine-month period ended December 31, 2025. The Board of Directors approved the standalone and consolidated un-audited financial results, along with the limited review reports issued by the statutory auditors. The review was conducted in accordance with the Standard on Review Engagements (SRE) 2410 and circular issued by the SEBI under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.